These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2951552)

  • 1. Vasopressin signaling in kidney cells.
    Ausiello DA; Skorecki KL; Verkman AS; Bonventre JV
    Kidney Int; 1987 Feb; 31(2):521-9. PubMed ID: 2951552
    [No Abstract]   [Full Text] [Related]  

  • 2. Receptors to vasopressin and other hormones in the mammalian kidney.
    Morel F; Imbert-Teboul M; Chabardès D
    Kidney Int; 1987 Feb; 31(2):512-20. PubMed ID: 3031358
    [No Abstract]   [Full Text] [Related]  

  • 3. Kinetic and pharmacological characterization of vasopressin membrane receptors from human kidney medulla: relation to adenylate cyclase activation.
    Guillon G; Butlen D; Cantau B; Barth T; Jard S
    Eur J Pharmacol; 1982 Dec; 85(3-4):291-304. PubMed ID: 6295785
    [No Abstract]   [Full Text] [Related]  

  • 4. Calcium-mediated interactions between the antidiuretic hormone and renal plasma membranes.
    Campbell BJ; Woodward G; Borberg V
    J Biol Chem; 1972 Oct; 247(19):6167-75. PubMed ID: 4346807
    [No Abstract]   [Full Text] [Related]  

  • 5. Potent antagonists of vasopressin antidiuretic activity that lack the beta,beta-cyclopentamethylene-beta-mercaptopropionic acid substitution at position 1.
    Yim NC; Moore ML; Huffman WF; Bryan HG; Chang HL; Kinter LB; Edwards R; Stassen FL; Schmidt D; Heckman G
    J Med Chem; 1986 Dec; 29(12):2425-6. PubMed ID: 2946863
    [No Abstract]   [Full Text] [Related]  

  • 6. Pathogenic role of cyclic AMP in the impairment of urinary concentrating ability in acute hypercalcemia.
    Beck N; Singh H; Reed SW; Murdaugh HV; Davis BB
    J Clin Invest; 1974 Nov; 54(5):1049-55. PubMed ID: 4371361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Vasopressin: the ontogeny of antidiuretic action at the cellular level].
    Ivanova LN; Zelenina MN; Melidi NN; Solenov EI; Khegaĭ II
    Fiziol Zh SSSR Im I M Sechenova; 1989 Jul; 75(7):970-9. PubMed ID: 2530119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence that monensin inhibits vasopressin-stimulated water flow at an early step in the receptor-adenylate cyclase sequence.
    Franki N; Mosenkis B; Hays RM
    Biol Cell; 1989; 66(1-2):19-22. PubMed ID: 2478241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular actions of vasopressin in the mammalian kidney.
    Dousa TP; Valtin H
    Kidney Int; 1976 Jul; 10(1):46-63. PubMed ID: 7704
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of aldosterone and vasopressin on adenyl cyclase activity of rat kidney.
    Lang MA; Edelman IS
    Am J Physiol; 1972 Jan; 222(1):21-4. PubMed ID: 4334058
    [No Abstract]   [Full Text] [Related]  

  • 11. Expression of vasopressin V2 receptor in Xenopus laevis oocytes by porcine kidney cell line (LLC-PK1) messenger RNA.
    Kimura K
    Biochem Biophys Res Commun; 1991 Jan; 174(1):149-55. PubMed ID: 1824918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic study of the effects of (8-arginine)- and (8-lysine)-vasopressins on adenyl cyclase activity of mouse kidney.
    Stewart AD
    J Endocrinol; 1974 Jun; 61(3):447-54. PubMed ID: 4366121
    [No Abstract]   [Full Text] [Related]  

  • 13. Vasopressin increases cytosolic free calcium in LLC-PK1 cells through a V1-receptor.
    Burnatowska-Hledin MA; Spielman WS
    Am J Physiol; 1987 Aug; 253(2 Pt 2):F328-32. PubMed ID: 2956892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasopressin antagonists.
    Jard S
    Adv Nephrol Necker Hosp; 1987; 16():1-15. PubMed ID: 2949544
    [No Abstract]   [Full Text] [Related]  

  • 15. Vasopressin antagonists: present and future.
    Hofbauer KG; Mah SC
    Kidney Int Suppl; 1987 Aug; 21():S76-82. PubMed ID: 3306108
    [No Abstract]   [Full Text] [Related]  

  • 16. Regulation of vasopressin binding to intact cells.
    Roy C; Ausiello DA
    Ann N Y Acad Sci; 1981; 372():92-105. PubMed ID: 6951430
    [No Abstract]   [Full Text] [Related]  

  • 17. Vascular vasopressin receptors mediate phosphatidylinositol turnover and calcium efflux in an established smooth muscle cell line.
    Aiyar N; Nambi P; Stassen FL; Crooke ST
    Life Sci; 1986 Jul; 39(1):37-45. PubMed ID: 3014249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of vasopressin antidiuretic action by alpha 2-adrenoceptors is species specific.
    Brooks DP; Gellai M; DePalma PD; Edwards RM
    Am J Physiol; 1991 Nov; 261(5 Pt 2):R1242-6. PubMed ID: 1659234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability of the vasopressin V2 receptor-adenylyl cyclase system in rat kidney.
    Shen T; Laycock J; Suzuki Y; Defer N; Hanoune J
    Eur J Pharmacol; 1998 Jan; 341(1):87-94. PubMed ID: 9489860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of renal medullary solutes on vasopressin-sensitive adenyl cyclase.
    Dousa TP
    Am J Physiol; 1972 Mar; 222(3):657-62. PubMed ID: 4336753
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.